发明授权
US07550619B2 Intermediates in the preparation of the antiviral agent [1S-(1α, 3α, 4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxmethyl)-2-methylenecyclopentyl]-6H-purin-6-one
有权
制备抗病毒剂的中间体[1S-(1α,3α,4beta)] - 2-氨基-1,9-二氢-9- [4-羟基-3-(羟甲基)-2-亚甲基环戊基] 嘌呤-6-酮
- 专利标题: Intermediates in the preparation of the antiviral agent [1S-(1α, 3α, 4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxmethyl)-2-methylenecyclopentyl]-6H-purin-6-one
- 专利标题(中): 制备抗病毒剂的中间体[1S-(1α,3α,4beta)] - 2-氨基-1,9-二氢-9- [4-羟基-3-(羟甲基)-2-亚甲基环戊基] 嘌呤-6-酮
-
申请号: US11311598申请日: 2005-12-19
-
公开(公告)号: US07550619B2公开(公告)日: 2009-06-23
- 发明人: Yadagiri R. Pendri , Chung-Pin H. Chen , Jing Liang , Shaopeng Wang , Milan Stojanovic , Richard P. Polniaszek , John Thottathil , Dhileepkumar Krishnamurty
- 申请人: Yadagiri R. Pendri , Chung-Pin H. Chen , Jing Liang , Shaopeng Wang , Milan Stojanovic , Richard P. Polniaszek , John Thottathil , Dhileepkumar Krishnamurty
- 申请人地址: US NJ Princeton
- 专利权人: Bristol-Myers Squibb Company
- 当前专利权人: Bristol-Myers Squibb Company
- 当前专利权人地址: US NJ Princeton
- 代理商 Jennifer Chin Chapman; James Epperson
- 主分类号: C07F7/04
- IPC分类号: C07F7/04 ; C07F7/08
摘要:
Intermediates useful in the preparation of the antiviral agent entecavir are disclosed. A resin adsorption process for the isolation and purification of entecavir is also disclosed. Various processes useful in the preparation of entecavir are also disclosed.
公开/授权文献
信息查询